Clovis Oncology Inc (CLVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | CLVS | EDSA | NCEL | ||
| Company | Clovis Oncology Inc | Edesa Biotech Inc | Newcelx Ltd | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 0.0808 | 1.4400 | 2.41 | ||
| High | 0.0977 | 1.4900 | 2.48 | ||
| Low | 0.0766 | 1.2905 | 2.12 | ||
| Latest | 0.0812 | 1.4800 | 2.14 | ||
| Change | -0.0048 | +0.0400 | -0.36 | ||
| % Change | -5.58% | +2.78% | -14.40% | ||
| Volume | 24,516,400 | 137,800 | 90,100 | ||
| 20-Day Average Volume | 9,433,500 | 44,230 | 92,410 | ||
| Previous Close | 0.0860 | 1.4400 | 2.50 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 0.2340 | 1.5951 | 3.15 | ||
| 20-Day Raw Stochastic | 1.73% | 37.61% | 0.74% | ||
| 20-Day Relative Strength | 23.83 | 39.34 | 28.54 | ||
| Weighted Alpha | -91.19 | -32.55 | -87.37 | ||
| Today's Opinion | 100% Sell | 100% Sell | 100% Sell | ||
| Previous Opinion | 100% Sell | 100% Sell | 100% Sell | ||
| Last Month's Opinion | 100% Sell | 72% Sell | 100% Sell | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | -39.04% since 12/13/22 | unch since 12/19/25 | -17.69% since 12/19/25 | ||
| Low | 0.0760 on 12/16/22 | 1.2750 on 12/24/25 | 2.12 on 12/29/25 | ||
| High | 0.1439 on 12/14/22 | 1.4990 on 12/22/25 | 2.72 on 12/26/25 | ||
| 1-Month | |||||
| %Chg | -76.74% since 11/18/22 | -15.43% since 11/28/25 | -46.63% since 11/28/25 | ||
| Low | 0.0760 on 12/16/22 | 1.2750 on 12/24/25 | 2.12 on 12/29/25 | ||
| High | 0.3772 on 12/01/22 | 1.8200 on 12/09/25 | 4.70 on 12/10/25 | ||
| 3-Month | |||||
| %Chg | -92.75% since 09/20/22 | -39.59% since 09/29/25 | -91.27% since 09/29/25 | ||
| Low | 0.0760 on 12/16/22 | 1.2750 on 12/24/25 | 2.12 on 12/29/25 | ||
| High | 1.3100 on 10/04/22 | 2.9500 on 10/22/25 | 22.40 on 09/30/25 | ||
| 6-Month | |||||
| %Chg | -93.12% since 06/17/22 | -27.80% since 06/27/25 | -92.33% since 06/27/25 | ||
| Low | 0.0760 on 12/16/22 | 1.2750 on 12/24/25 | 2.12 on 12/29/25 | ||
| High | 3.2500 on 07/08/22 | 2.9500 on 10/22/25 | 30.80 on 06/30/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 11,770 | 12,001 | 11,396 | ||
| Shares Outstanding, K | 144,955 | 8,334 | 4,558 | ||
| Annual Sales | 148,760,000 | 0 | 0 | ||
| Annual Net Income | -264,520,000 | -7,190,000 | -1,980,000 | ||
| Last Quarter Sales | 30,660,000 | 0 | N/A | ||
| Last Quarter Net Income | -56,010,000 | -2,230,000 | -5,847,000 | ||
| 60-Month Beta | 0.24 | 0.08 | 0.12 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.39 on 11/09/22 | -0.32 on 12/12/25 | N/A on 08/25/20 | ||
| Latest Earnings Date | 02/22/23 | 02/13/26 | 01/01/70 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||